Field scale quantification of microbial transport from bovine faeces under simulated rainfall events. Journal of Water and Health. 0.5(1),
(2007). Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92. Microbial Pathogenesis. 43, 2.
(2007). Type VI secretion is a major virulence determinant in Burkholderia mallei. Molecular Microbiology. 64, 6.
(2007). (2006).
Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q Fever. Infection and Immunity. 74, 11.
(2006). Murine Hepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice. Journal of Virology. 80, 21.
(2006). Occurrence of infected amoebae in cooling towers compared with natural aquatic environments: implications for emerging pathogens. Environmental science & technology. 40, 7440–7444.
(2006). Surveillance for waterborne disease and outbreaks associated with recreational water - United States, 2003-2004. Morbidity and Mortality Weekly Report. 55(SS12),
(2006). Waterborne toxoplasmosis, Brazil, from field to gene. Emerging Infectious Disease. 12,
(2006). Dose response modelling of Escherichia coli O157 incorporating data from foodborne and environmental outbreaks. International Journal of Food Microbiology. 103, 1.
(2005). (2005). Refractory periods and climate forcing in cholera dynamics. Nature Letters. 436(4),
(2005). Remediation of Bacillus anthracis contamination in the US Department of Justice mail facility. Biosecurity and bioterrorism: biodefense strategy, practice, and science. 3, 119–127.
(2005). (2005). (2004).
Legionella infection risk from domestic hot water. Emerging infectious diseases. 10, 457.
(2004). (2004). (2004). Shigellosis: challenges & management issues. Indian Journal of Medical Research. 120(5),
(2004). (2004). Infections of the Gastrointestinal Tract. PRACTICAL GASTROENTEROLOGY. 63.
(2003). Q fever: a biological weapon in your backyard. The Lancet Infectious Diseases. 3,
(2003). (2003). Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
(2002). Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
(2002).